BRIEF RESEARCH REPORT article
Front. Med.
Sec. Precision Medicine
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1620405
This article is part of the Research TopicMolecular Informatics in Personalized Medicine - Volume IIView all articles
Accurate and rapid single nucleotide variation detection in PCSK9 gene using Nanopore sequencing
Provisionally accepted- 1Monzino Cardiology Center (IRCCS), Milan, Italy
- 2Department of Biomedical, Surgical and Dental Sciences, Faculty of Medicine and Surgery, University of Milan, Milan, Lombardy, Italy
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Genetic testing is essential for disease screening, diagnosis, prognosis, and pharmacotherapy guidance. Oxford Nanopore Technologies (ONT) offers a cost-effective platform for long-read sequencing, yet its routine use in clinical diagnostics remains under evaluation. We tested different nanopore sequencing pipelines aimed at accurately detecting single-nucleotide variants (SNV) in a gene locus spanning ⁓25 kb.Methods: As a proof of concept, PCSK9 was selected for its relevance to cardiovascular disease and suitable sequence structure. Twelve subjects were analyzed using different sequencing flow cells, basecalling models, and SNV calling algorithms. Sanger sequencing served as the reference for performance validation. Sequencing throughput per flow cell was also estimated.The combination of super high accuracy (SUP) basecalling with Longshot variant calling demonstrated the highest performance across flow cells. MinION flow cell reached a perfect F1-score of 100%, while the more cost-effective Flongle flow cell remained a viable alternative (mean F1-score: 98.2% ± 4.2). Throughput analysis indicated that a single MinION flow cell could process up to 96 samples and ⁓40 long sequencing regions, whereas a Flongle flow cell could support sequencing of 96 samples and one long region.The proposed nanopore-based SNV identification workflows may support the development of long-read, targeted gene panels, offering a promising tool for both diagnostic and discovery applications, particularly in multi-gene settings such as oncology and cardiology.
Keywords: Third-generation sequencing, nanopore sequencing, Single nucleotide variation, Variant calling, pcsk9, cardiovascular disease
Received: 29 Apr 2025; Accepted: 01 Aug 2025.
Copyright: © 2025 Massaiu, Valerio, Rusconi, Bertolini, De Giorgi, Myasoedova and Poggio. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Ilaria Massaiu, Monzino Cardiology Center (IRCCS), Milan, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.